Annual Retained Earnings
-$899.47 M
-$234.33 M-35.23%
December 31, 2024
Summary
- As of March 12, 2025, XENE annual retained earnings is -$899.47 million, with the most recent change of -$234.33 million (-35.23%) on December 31, 2024.
- During the last 3 years, XENE annual retained earnings has fallen by -$542.10 million (-151.69%).
- XENE annual retained earnings is now -767.09% below its all-time high of -$103.73 million, reached on December 31, 2014.
Performance
XENE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$899.47 M
-$65.69 M-7.88%
December 31, 2024
Summary
- As of March 12, 2025, XENE quarterly retained earnings is -$899.47 million, with the most recent change of -$65.69 million (-7.88%) on December 31, 2024.
- Over the past year, XENE quarterly retained earnings has stayed the same.
- XENE quarterly retained earnings is now -767.09% below its all-time high of -$103.73 million, reached on December 31, 2014.
Performance
XENE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
XENE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.2% | 0.0% |
| 3 y3 years | -151.7% | -138.6% |
| 5 y5 years | -260.3% | -138.6% |
XENE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -151.7% | at low | -151.7% | at low |
| 5 y | 5-year | -260.3% | at low | -260.3% | at low |
| alltime | all time | -767.1% | at low | -767.1% | at low |
Xenon Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$899.47 M(+35.2%) | -$899.47 M(+7.9%) |
| Sep 2024 | - | -$833.78 M(+8.1%) |
| Jun 2024 | - | -$771.00 M(+8.1%) |
| Mar 2024 | - | -$713.07 M(+7.2%) |
| Dec 2023 | -$665.14 M(+37.8%) | -$665.14 M(+7.2%) |
| Sep 2023 | - | -$620.40 M(+8.5%) |
| Jun 2023 | - | -$571.93 M(+9.0%) |
| Mar 2023 | - | -$524.47 M(+8.6%) |
| Dec 2022 | -$482.75 M(+35.1%) | -$482.75 M(+8.4%) |
| Sep 2022 | - | -$445.35 M(+9.1%) |
| Jun 2022 | - | -$408.20 M(+8.3%) |
| Mar 2022 | - | -$377.04 M(+5.5%) |
| Dec 2021 | -$357.37 M(+28.3%) | -$357.37 M(+7.7%) |
| Sep 2021 | - | -$331.81 M(+4.9%) |
| Jun 2021 | - | -$316.37 M(+7.5%) |
| Mar 2021 | - | -$294.26 M(+5.7%) |
| Dec 2020 | -$278.49 M(+11.6%) | -$278.49 M(+4.6%) |
| Sep 2020 | - | -$266.17 M(+3.4%) |
| Jun 2020 | - | -$257.31 M(+0.1%) |
| Mar 2020 | - | -$257.14 M(+3.0%) |
| Dec 2019 | -$249.66 M | -$249.66 M(+4.8%) |
| Sep 2019 | - | -$238.28 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -$229.41 M(+4.6%) |
| Mar 2019 | - | -$219.40 M(+5.5%) |
| Dec 2018 | -$207.88 M(+19.9%) | -$207.88 M(+4.3%) |
| Sep 2018 | - | -$199.33 M(+7.8%) |
| Jun 2018 | - | -$184.94 M(+4.4%) |
| Mar 2018 | - | -$177.14 M(+2.2%) |
| Dec 2017 | -$173.39 M(+21.5%) | -$173.39 M(+4.9%) |
| Sep 2017 | - | -$165.32 M(+4.9%) |
| Jun 2017 | - | -$157.58 M(+4.9%) |
| Mar 2017 | - | -$150.20 M(+5.3%) |
| Dec 2016 | -$142.68 M(+19.2%) | -$142.68 M(+4.4%) |
| Sep 2016 | - | -$136.70 M(+6.0%) |
| Jun 2016 | - | -$128.97 M(+4.9%) |
| Mar 2016 | - | -$122.96 M(+2.7%) |
| Dec 2015 | -$119.69 M(+15.4%) | -$119.69 M(+3.4%) |
| Sep 2015 | - | -$115.75 M(+3.5%) |
| Jun 2015 | - | -$111.80 M(+3.5%) |
| Mar 2015 | - | -$108.00 M(+4.1%) |
| Dec 2014 | -$103.73 M(-11.2%) | -$103.73 M(-1.2%) |
| Sep 2014 | - | -$104.96 M(-8.1%) |
| Jun 2014 | - | -$114.15 M(-2.2%) |
| Dec 2013 | -$116.75 M(-9.3%) | -$116.75 M |
| Dec 2012 | -$128.78 M | - |
FAQ
- What is Xenon Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual retained earnings year-on-year change?
- What is Xenon Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly retained earnings year-on-year change?
What is Xenon Pharmaceuticals annual retained earnings?
The current annual retained earnings of XENE is -$899.47 M
What is the all time high annual retained earnings for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual retained earnings is -$103.73 M
What is Xenon Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, XENE annual retained earnings has changed by -$234.33 M (-35.23%)
What is Xenon Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of XENE is -$899.47 M
What is the all time high quarterly retained earnings for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly retained earnings is -$103.73 M
What is Xenon Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, XENE quarterly retained earnings has changed by $0.00 (0.00%)